Fast Five Quiz: Chronic Lymphocytic Leukemia (CLL) Treatment

Karl J. D'Silva, MD; Christina Poh, MD


November 02, 2021

Many different treatments are available for the management of chronic lymphocytic leukemia (CLL), including a variety of small-molecule inhibitors, such as Bruton tyrosine kinase (BTK) and B-cell lymphoma 2 (BCL-2) inhibitors, as well as traditional chemoimmunotherapy. The optimal treatment approach for CLL is based on a combination of patient- and disease-specific factors. Are you up-to-date on current treatment recommendations for CLL?


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.